Royal Bank of Canada »

Intellia Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.7M 154k 30.49
2023-09-30 $2.6M 84k 31.43
2023-06-30 $1.4M 33k 40.74
2022-12-31 $1.3M 36k 34.74
2022-09-30 $1.1M 19k 55.83
2021-06-30 $3.6M 23k 161.70
2021-03-31 $1.9M 24k 80.18
2020-12-31 $6.9M 126k 54.36
2020-09-30 $2.5M 126k 19.73
2020-06-30 $2.7M 128k 21.04
2020-03-31 $0 119k 0.00
2019-12-31 $1.8M 124k 14.74
2019-09-30 $1.8M 132k 13.35
2019-03-31 $604k 35k 17.08
2018-12-31 $442k 32k 13.64
2018-09-30 $1.1M 39k 28.76
2018-06-30 $1.1M 39k 29.41
2018-03-31 $639k 30k 21.09
2017-12-31 $63k 4.9k 12.99
2016-12-31 $124k 8.9k 13.86
2016-09-30 $113k 8.0k 14.08